Latest News & Features
Big Pharma
Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted. 12 January 2023
Americas
Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma. 10 January 2023
article
German IP specialist gears up for UPC with experienced partner | Patent litigator previously led practice at IP boutique Meissner Bolte. 10 January 2023
Genetics
Science fiction is becoming science fact but the Alice/Mayo framework throws up some interesting challenges to bringing life back from the dead, explains Brian Hausman of Baker Botts. 5 January 2023
Europe
‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies. 5 January 2023
Americas
Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server. 4 January 2023
Medtech
Bringing a medical device to market relies on a broad understanding of IP, explain Sabing Lee and Kregg Koch of Knobbe Martens. 3 January 2023
Big Pharma
California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders. 3 January 2023
Americas
Addition is a former chair of a patent practice group | New partner has expertise in complex disputes over medical devices | Barnes & Thornburg | Patterson Thuente Pedersen. 22 December 2022
Big Pharma
Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations. 22 December 2022